MBXBFMicrobix BiosystemsMBXBF info
$0.26info0.00%24h
Global rank27139
Market cap$35.37M
Change 7d-3.36%
YTD Performance-7.83%
SP500 benchmarkUnderperform
P/E0
P/S2.92
Revenue$12.13M
Earnings-$29.00K
Dividend yield-
Main Sector
Healthcare

Microbix Biosystems (MBXBF) Stock Overview

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

MBXBF Stock Information

Symbol
MBXBF
Address
265 Watline AvenueMississauga, ON L4Z 1P3Canada
Founded
-
Trading hours
-
Website
https://www.microbix.com
Country
🇨🇦 Canada
Phone Number
905 361 8910

Microbix Biosystems (MBXBF) Price Chart

-
Value:-

Microbix Biosystems Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.259
N/A
Market Cap
$35.37M
N/A
Shares Outstanding
136.55M
0.87%
Employees
0
N/A
Shareholder Equity
24.62M
-1.26%
Valuation
2023
Change
P/S Ratio
2.92
N/A
P/B Ratio
1.44
N/A
Growth
2023
Change
Return on Equity
-0.0012
N/A
Earnings
2023
Change
Revenue
$12.13M
N/A
Earnings
-$29.00K
N/A
Gross Margin
0.453
N/A
Operating Margin
-0.1657
N/A
Net income margin
-0.0024
N/A
Financial Strength
2023
Change
Total Assets
$26.19M
N/A
Total Debt
$4.88M
N/A
Cash on Hand
$8.53M
N/A
Debt to Equity
0.3290
36.10%
Cash to Debt
$1.75
-24.59%
Current Ratio
$5.13
-39.36%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org